 |
市场调查报告书
商品编码
1149865
糖生物学市场：按产品类型、应用、最终用户、地区划分——规模、份额、展望、机会分析2022-2030Glycobiology Market, by Product Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 |
||||||
价格
简介目录
糖生物学是研究聚醣和糖基化生物分子（如醣脂、糖蛋白和糖基化小分子）的科学分支。聚醣在生活的方方面面无处不在。脂质、蛋白质、代谢物和核酸等生物分子与聚醣结构的结合极大地影响了它们的理化性质、亚细胞定位、免疫原性、药代动力学和药效学。
所有细胞和许多蛋白质（包括糖蛋白）都覆盖着密集而復杂的共价连接聚醣阵列（称为寡糖或聚醣）。这些聚醣的生物学作用在构建复杂的多细胞器官和生物体的过程中尤为重要，这些过程需要细胞之间以及与周围细胞外基质的相互作用。大多数类型的聚醣存在于细胞表面和分泌的大分子中。此外，简单、快速代谢的蛋白质结合糖链在细胞核和细胞质中含量丰富，并起到调节开关的作用。
聚醣是多种多样的复杂分子，其功能由其独特的结构决定。聚醣结构需要有效的□促工具和分析技术，并且可以与特定功能相关联。聚醣调节蛋白质和细胞的粘附。免疫系统主要通过碳水化合物-蛋白质相互作用发挥作用，突出了碳水化合物在生理学、病原体识别、癌症和自身免疫性疾病中的重要性。
市场动态
推动糖生物学市场增长的关键因素包括采用无机增长策略，例如市场参与者的收购。例如，2018 年 6 月，美国生命科学公司安捷伦科技收购了聚醣分析、试剂和试剂盒的私营供应商 ProZyme Inc.。此次收购将扩大公司的糖生物学产品组合
这项研究的主要特点
- 本报告对全球糖生物学市场进行了深入分析，提供了以 2021 年为基准年的预测期 (2022-2030) 的市场规模和復合年增长率 (CAGR%)。
- 解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
- 它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
- 根据公司亮点、产品组合、主要亮点、财务业绩和战略等参数，介绍全球糖生物学市场的主要参与者概况。
- 本研究涵盖的主要公司包括 Tracxn Technologies Limited、Agilent Technologies, Inc.、Blirt.eu、Takara Bio Inc.、Bio-Techne、Bruker Corporation、Thermo Fisher Scientific Inc.、Shimadzu Corporation、New England Biolabs ., Waters.co., Merck KGaA, Palleon Pharmaceuticals, Asparia Glycomics, RayBiotech Life, Inc., Z Biotech, LLC., Chemily Glycoscience, Lectenz Bio, 2BScientific, and Glycodiag
- 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
- 《全球糖生物学市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
- 利益相关者可以通过用于分析全球糖生物学市场的各种战略矩阵来促进决策制定。
内容
第 1 章目的和先决条件
- 调查目的
- 先决条件
- 缩写说明
第二章市场展望
- 报告内容
- 市场定义和范围
- 执行摘要
- 按产品类型划分的市场概况
- 市场概况：按应用分类
- 市场概况：按最终用户分类
- 市场概况：按地区
- 连贯机会图 (COM)
第3章市场动态、规律及趋势分析
- 市场动态
- 司机
- 约束因素
- 市场机会
- 影响分析
- 产品发布
- 监管情景
- 主要发展状况
- 害虫分析
第 4 章全球糖生物学市场 - 冠状病毒 (COVID-19) 大流行的影响
- 对医疗保健行业的总体影响
- 对供需的影响
- COVID-19 对市场的影响
第 5 章全球糖生物学市场：按产品类型，2017-2030
- 设备
- □
- 糖甘□
- GlcNAc 转移□
- GalNAc 转移□
- 岩藻糖基转移□
- 半乳糖基转移□
- 碳水化合物激□
- 其他
- 消耗品
- 试剂和试剂盒
第 6 章全球糖生物学市场应用，2017-2030
- 诊断用途
- 工业应用
- 治疗用途
- 药物发现和药物开发
- 其他
第 7 章最终用户的全球糖生物学市场，2017-2030
- 研究所
- 医院
- 诊断中心
- 生物製药公司
- 其他
第 8 章按地区分列的全球糖生物学市场，2017-2030
- 北美
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲地区
- 欧洲
- 英国
- 德国
- 意大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲地区
- 亚太地区
- 中国
- 印度
- 日本
- 东盟
- 澳大利亚
- 韩国
- 其他亚太地区
- 中东
- 海湾合作委员会
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中非
- 南非
第9章竞争格局
- Tracxn Technologies Limited
- Agilent Tecnologies, Inc
- Blirt.eu
- Takara Bio Inc.
- Bio-Techne
- Bruker Corporation
- Thermo Fisher Scientific Inc
- Shimadzu Corporation
- New England Biolabs.
- Waters.co.
- Merck KGaA
- Palleon Pharmaceuticals
- Asparia Glycomics
- RayBiotech Life, Inc
- Z Biotech, LLC
- Chemily Glycoscience
- Lectenz Bio,
- 2BScientific
- Glycodiag
第 10 章
- 调查方法
- 关于出版商
简介目录
Product Code: CMI3639
Glycobiology is the branch of science which deals with the study of Glycan and glycan-modified biomolecules such as glycolipids, glycoproteins and glycosylated small molecules collectively referred to as sugar molecules. Glycan are universal in all aspects of life. The binding of carbohydrate structures to biomolecules, including lipids, proteins, metabolites, and nucleic acids, can profoundly affect their physicochemical properties, subcellular localization, immunogenicity, and pharmacokinetics and pharmacodynamics.
All cells and many proteins such as glycoproteins are covered with dense and complex arrays of covalently linked sugar chains (called oligosaccharides or glycan). The biological roles of these glycan are of particular importance in the assembly of complex multicellular organs and organisms, processes that require interactions between cells and with the surrounding extracellular matrix. Most classes of glycan are found on the surface of cells and secreted macromolecules. In addition, simple, rapidly metabolizing protein-bound glycan are abundant in the nucleus and cytoplasm, where they function as regulatory switches.
Glycan are diverse and complex molecules whose functions are determined by their unique structures. Glycan structures requires effective enzymatic tools and analytical techniques and can be associated with specific functions. Glycosylation defines the adhesive properties of proteins and cells. The immune system functions primarily through carbohydrate-protein interactions, highlighting the importance of carbohydrates in physiology, pathogen recognition, cancer, and autoimmune diseases.
Market Dynamics
Major factors driving growth of the glycobiology market include adoption of inorganic growth strategies such as acquisitions by key players in the market. For instance, in June, 2018, Agilent Technologies, an American life science company, has acquired privately held ProZyme Inc., a provider of glycan analysis, reagents and kits. This acquisition will help the company expand its glycobiology product portfolio
Key features of the study:
- This report provides in-depth analysis of the global glycobiology market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global glycobiology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Tracxn Technologies Limited, Agilent Tecnologies,Inc., Blirt.eu, Takara Bio Inc., Bio-Techne, Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, New England Biolabs., Waters.co., Merck KGaA, Palleon Pharmaceuticals, Asparia Glycomics, RayBiotech Life, Inc., Z Biotech, LLC., Chemily Glycoscience, Lectenz Bio, 2BScientific , and Glycodiag
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global glycobiology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global glycobiology market
Detailed Segmentation:
- Global Glycobiology Market, By Product Type:
- Instruments
- Enzymes
- Glycosidase
- Heparinase
- Chitinase
- Acetylgalactosaminidase
- PNGase
- Chitobiase
- Others
- GlcNAc Transferases
- Acetylglucosaminyltransferase
- Exostosin
- Others
- GalNAc Transferases
- Polypeptide GalNAc Transferase
- GANLTL
- Others
- Fucosyl Transferases
- Galactosyl Transferases
- Carbohydrate Kinases
- Others
- Consumables
- Reagents & Kits
- Global Glycobiology Market, By Application:
- Diagnostic Application
- Industrial Application
- Therapeutic Application
- Drug Discovery and Development
- Others
- Global Glycobiology Market, By End User:
- Research Laboratories
- Hospitals
- Diagnostic Centres
- Biopharmaceutical Companies
- Others
- Global Glycobiology Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Tracxn Technologies Limited
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Agilent Tecnologies, Inc
- Blirt.eu
- Takara Bio Inc.
- Bio-Techne.
- Bruker Corporation
- Thermo Fisher Scientific Inc
- Shimadzu Corporation
- New England Biolabs.
- Waters.co.
- Merck KGaA
- Palleon Pharmaceuticals
- Asparia Glycomics
- RayBiotech Life, Inc.
- Z Biotech, LLC.
- Chemily Glycoscience
- Lectenz Bio
- 2BScientific
- Glycodiag
- Tracxn Technologies Limited
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Product Launches
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Glycobiology Market- Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact on Healthcare sector
- Impact on Supply and Demand
- COVID-19 Impact on the market
5. Global Glycobiology Market, By Product Type, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Enzymes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Glycosidase
- Heparinase
- Chitinase
- Acetylgalactosaminidase
- PNGase
- Chitobiase
- Others
- GlcNAc Transferases
- Acetylglucosaminyltransferase
- Exostosin
- Other
- GalNAc Transferases
- Polypeptide GalNAc Transferase
- GANLTL
- Others
- Fucosyl Transferases
- Galactosyl Transferases
- Carbohydrate Kinases
- Others
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Reagents & Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
6. Global Glycobiology Market, By Application, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Diagnostic Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Industrial Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Therapeutic Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
7. Global Glycobiology Market, By End User, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Diagnostic Centres
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
8. Global Glycobiology Market, By Region, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Tracxn Technologies Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Agilent Tecnologies, Inc
- Blirt.eu
- Takara Bio Inc.
- Bio-Techne
- Bruker Corporation
- Thermo Fisher Scientific Inc
- Shimadzu Corporation
- New England Biolabs.
- Waters.co.
- Merck KGaA
- Palleon Pharmaceuticals
- Asparia Glycomics
- RayBiotech Life, Inc
- Z Biotech, LLC
- Chemily Glycoscience
- Lectenz Bio,
- 2BScientific
- Glycodiag
10. Section
- Research Methodology
- About Us
